Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.

Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37534070

about

Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Semi-quantitative measurement of a specific glycoform using a DNA-tagged antibody and lectin affinity chromatography for glyco-biomarker development Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatoce Neuraminidase 1 (NEU1) promotes proliferation and migration as a diagnostic and prognostic biomarker of hepatocellular carcinoma.Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and 18 F-fluoro-2-deoxyglucose positron emission tomography.FUT2 genetic variants as predictors of tumor development with hepatocellular carcinoma.Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells.Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers.Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis

P2860

Q26743361-A5130BDB-FE24-471D-8ACA-3776B4DB16A5 Q26772324-82D7AA27-50F2-4E79-85EA-FE9C2DCBF05F Q27311617-CA4C73EC-7433-46AA-A686-1894E1EFE6E7 Q28555059-B4440082-927F-439D-BCFC-BDA65BDB8313 Q37328031-3414B49F-BB3C-4022-9F2B-A46117538F9C Q37429938-F51480C4-015D-461B-9824-E7BFBBB4B303 Q37662166-EA35C9F5-E708-4DCB-AB51-80D4F4C2AB49 Q39225076-F4E75DEF-15A2-4BDF-9C8E-5934DC196128 Q41455314-3AA7DCAB-8CFF-4751-8D22-24A4F20F3217 Q47552123-0039DB37-A8BE-4DB2-93C2-A598E6214ABF Q51130491-EBDAF5FD-7130-4CD5-A43D-DEB64024818D Q58561237-E630941E-A4D5-487C-96C5-89A19AB1DE34

P2860

Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37534070

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@en

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@nl

type

label

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@en

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@nl

prefLabel

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@en

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@nl

P1433

Q37534070-C70316A7-7182-45CD-A6C2-28ECBA059081

P1476

Q37534070-7D1CE22F-4865-4424-A7BC-81C26DCFA2C2

P2093

Q37534070-07779032-AEAB-40A6-9335-8695A2668D11

Q37534070-35A63DA6-AD1B-45AB-A083-CEAA3722D186

Q37534070-494937AD-C03E-42CB-9FC4-D7DFDDC680BB

Q37534070-67037178-E230-46ED-8257-840F7487A320

Q37534070-6D8A8781-40FF-4284-BA65-D145A2279AD3

Q37534070-76D4DD23-0286-472E-BF83-8FCFE478906E

Q37534070-8A83D6DD-ED3F-4AB2-8DEC-448A0908AB2A

Q37534070-C84874D4-D146-455C-9438-FA57E6A67DB9

Q37534070-E44DF1ED-F6E1-45BD-96B9-A5852CC2E646

P275

Q37534070-DBCE0886-6A56-4FB0-B16E-25247938DED9

P2860

Q37534070-247EABFF-2A8E-4935-9C2B-830E9D1F698D

Q37534070-276AC04F-90AC-475E-B2C5-32B7BF12ED9F

Q37534070-32F7B18A-AE5B-46BC-A817-BB7BEFBDED79

Q37534070-5CD4B82C-85CC-4687-9EB9-D971DC884CDD

Q37534070-63FC5F0B-A5CD-4CAC-8065-D87660ED7C7B

Q37534070-64D965F9-83A6-43A8-B308-EFAFF6A2F246

Q37534070-7169DDA8-F179-4503-B702-E975552EC6AC

Q37534070-7F7F306B-75F0-4EFC-8D62-2550FC328E23

Q37534070-810BCA2A-34A1-4948-8ABB-2ABEA9EE4BD6

Q37534070-8A80DBB1-227E-45C4-ABE3-F760E408F9D3

P304

Q37534070-3882649C-0306-4DFE-9C37-657754D19000

P31

Q37534070-3DBA4AC9-E162-4C05-B046-45C63BBF4492

Q37534070-4F0AB5CB-C97D-4CD5-89B9-B624C1A8E4C6

Q37534070-faf0c871-acbc-46a8-9984-2ab3c93870a4

P356

Q37534070-9D560F63-C4B2-48D7-A01A-60711710ED08

P407

Q37534070-7A820643-D1BF-4A3E-BA71-CE6D3CA8F817

P433

Q37534070-888BA4D7-C7E8-4A87-A1C5-34B47DEBF3EF

P478

Q37534070-E2F16360-CF93-4F18-833F-309B13E70A96

P5008

Q37534070-3772895F-7B1F-4971-95E0-84C2E12B8ADA

P577

Q37534070-75245A1F-2ED1-49CB-878E-37F579940CC4

P5875

Q37534070-6EA20401-6A86-41BC-8768-22E6636FB7F6

P698

Q37534070-0461B9C0-149E-42C8-882C-17738A14AA78

P921

Q37534070-3945ACA5-3EE8-4015-BB1F-4CFF87C0D939

Q37534070-4F8CD747-1EDD-4A40-9EBA-131C75028F7C

Q37534070-75BAA10A-FBF7-48AF-97B0-7A642F6B9545

Q37534070-827A1F41-97B7-44FD-83E0-939378E6309C

Q37534070-85B240BF-880D-4AD7-AA8B-28CA49356C2D

Q37534070-9A5F410A-E234-4DFB-A742-91AC42877341

Q37534070-AB5FAFF7-8C65-4E6F-A8BB-78563DA5F410

P932

Q37534070-45C3B6DB-F3F5-41D9-908C-2E09BAC3894F

P356

JOURNAL.PONE.0087011

P1433

P1476

Prognostic role of pre-treatme ...... atic review and meta-analysis.

@en

P2093

Bo Wang

http://www.w3.org/2001/XMLSchema#string

Jiwen Cheng

http://www.w3.org/2001/XMLSchema#string

Muxing Li

http://www.w3.org/2001/XMLSchema#string

Wanli Wang

http://www.w3.org/2001/XMLSchema#string

Xi Liu

http://www.w3.org/2001/XMLSchema#string

Yi Lv

http://www.w3.org/2001/XMLSchema#string

Yingjun Zhang

http://www.w3.org/2001/XMLSchema#string

Zheng Wu

http://www.w3.org/2001/XMLSchema#string

Zhengwen Liu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Cancer statistics, 2013

How should meta-regression analyses be undertaken and interpreted?

Hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis.

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

P304

e87011

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0087011

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260108767

http://www.w3.org/2001/XMLSchema#string

P698

24498011

http://www.w3.org/2001/XMLSchema#string

P921

hepatocellular carcinoma

tumor biomarkers

P932

3907387

http://www.w3.org/2001/XMLSchema#string